Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cannabis-based Medicines Market Growth (Status and Outlook) 2022-2028

  • LP 4917379
  • 89 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cannabis-based Medicines will have significant change from previous year. According to our (LP Information) latest study, the global Cannabis-based Medicines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cannabis-based Medicines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cannabis-based Medicines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cannabis-based Medicines market, reaching US$ million by the year 2028. As for the Europe Cannabis-based Medicines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cannabis-based Medicines players cover GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, and Axim Biotechnologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis-based Medicines market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

CBD (Cannabidiol) Based

THC (Tetrahydrocannabinol) Based

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Oral Solution

Tablets

Patches

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

GW Pharmaceuticals plc

INSYS Therapeutics

Aequus Pharmaceuticals

Axim Biotechnologies

Revive Therapeutics

MGC Pharmaceuticals

ECHO Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cannabis-based Medicines Market Size 2017-2028

2.1.2 Cannabis-based Medicines Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cannabis-based Medicines Segment by Type

2.2.1 CBD (Cannabidiol) Based

2.2.2 THC (Tetrahydrocannabinol) Based

2.2.3 Others

2.3 Cannabis-based Medicines Market Size by Type

2.3.1 Cannabis-based Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

2.4 Cannabis-based Medicines Segment by Application

2.4.1 Oral Solution

2.4.2 Tablets

2.4.3 Patches

2.4.4 Others

2.5 Cannabis-based Medicines Market Size by Application

2.5.1 Cannabis-based Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

3 Cannabis-based Medicines Market Size by Player

3.1 Cannabis-based Medicines Market Size Market Share by Players

3.1.1 Global Cannabis-based Medicines Revenue by Players (2020-2022)

3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2020-2022)

3.2 Global Cannabis-based Medicines Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cannabis-based Medicines by Regions

4.1 Cannabis-based Medicines Market Size by Regions (2017-2022)

4.2 Americas Cannabis-based Medicines Market Size Growth (2017-2022)

4.3 APAC Cannabis-based Medicines Market Size Growth (2017-2022)

4.4 Europe Cannabis-based Medicines Market Size Growth (2017-2022)

4.5 Middle East & Africa Cannabis-based Medicines Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cannabis-based Medicines Market Size by Country (2017-2022)

5.2 Americas Cannabis-based Medicines Market Size by Type (2017-2022)

5.3 Americas Cannabis-based Medicines Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cannabis-based Medicines Market Size by Region (2017-2022)

6.2 APAC Cannabis-based Medicines Market Size by Type (2017-2022)

6.3 APAC Cannabis-based Medicines Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cannabis-based Medicines by Country (2017-2022)

7.2 Europe Cannabis-based Medicines Market Size by Type (2017-2022)

7.3 Europe Cannabis-based Medicines Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cannabis-based Medicines by Region (2017-2022)

8.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2017-2022)

8.3 Middle East & Africa Cannabis-based Medicines Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cannabis-based Medicines Market Forecast

10.1 Global Cannabis-based Medicines Forecast by Regions (2023-2028)

10.1.1 Global Cannabis-based Medicines Forecast by Regions (2023-2028)

10.1.2 Americas Cannabis-based Medicines Forecast

10.1.3 APAC Cannabis-based Medicines Forecast

10.1.4 Europe Cannabis-based Medicines Forecast

10.1.5 Middle East & Africa Cannabis-based Medicines Forecast

10.2 Americas Cannabis-based Medicines Forecast by Country (2023-2028)

10.2.1 United States Cannabis-based Medicines Market Forecast

10.2.2 Canada Cannabis-based Medicines Market Forecast

10.2.3 Mexico Cannabis-based Medicines Market Forecast

10.2.4 Brazil Cannabis-based Medicines Market Forecast

10.3 APAC Cannabis-based Medicines Forecast by Region (2023-2028)

10.3.1 China Cannabis-based Medicines Market Forecast

10.3.2 Japan Cannabis-based Medicines Market Forecast

10.3.3 Korea Cannabis-based Medicines Market Forecast

10.3.4 Southeast Asia Cannabis-based Medicines Market Forecast

10.3.5 India Cannabis-based Medicines Market Forecast

10.3.6 Australia Cannabis-based Medicines Market Forecast

10.4 Europe Cannabis-based Medicines Forecast by Country (2023-2028)

10.4.1 Germany Cannabis-based Medicines Market Forecast

10.4.2 France Cannabis-based Medicines Market Forecast

10.4.3 UK Cannabis-based Medicines Market Forecast

10.4.4 Italy Cannabis-based Medicines Market Forecast

10.4.5 Russia Cannabis-based Medicines Market Forecast

10.5 Middle East & Africa Cannabis-based Medicines Forecast by Region (2023-2028)

10.5.1 Egypt Cannabis-based Medicines Market Forecast

10.5.2 South Africa Cannabis-based Medicines Market Forecast

10.5.3 Israel Cannabis-based Medicines Market Forecast

10.5.4 Turkey Cannabis-based Medicines Market Forecast

10.5.5 GCC Countries Cannabis-based Medicines Market Forecast

10.6 Global Cannabis-based Medicines Forecast by Type (2023-2028)

10.7 Global Cannabis-based Medicines Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GW Pharmaceuticals plc

11.1.1 GW Pharmaceuticals plc Company Information

11.1.2 GW Pharmaceuticals plc Cannabis-based Medicines Product Offered

11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GW Pharmaceuticals plc Main Business Overview

11.1.5 GW Pharmaceuticals plc Latest Developments

11.2 INSYS Therapeutics

11.2.1 INSYS Therapeutics Company Information

11.2.2 INSYS Therapeutics Cannabis-based Medicines Product Offered

11.2.3 INSYS Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 INSYS Therapeutics Main Business Overview

11.2.5 INSYS Therapeutics Latest Developments

11.3 Aequus Pharmaceuticals

11.3.1 Aequus Pharmaceuticals Company Information

11.3.2 Aequus Pharmaceuticals Cannabis-based Medicines Product Offered

11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Aequus Pharmaceuticals Main Business Overview

11.3.5 Aequus Pharmaceuticals Latest Developments

11.4 Axim Biotechnologies

11.4.1 Axim Biotechnologies Company Information

11.4.2 Axim Biotechnologies Cannabis-based Medicines Product Offered

11.4.3 Axim Biotechnologies Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Axim Biotechnologies Main Business Overview

11.4.5 Axim Biotechnologies Latest Developments

11.5 Revive Therapeutics

11.5.1 Revive Therapeutics Company Information

11.5.2 Revive Therapeutics Cannabis-based Medicines Product Offered

11.5.3 Revive Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Revive Therapeutics Main Business Overview

11.5.5 Revive Therapeutics Latest Developments

11.6 MGC Pharmaceuticals

11.6.1 MGC Pharmaceuticals Company Information

11.6.2 MGC Pharmaceuticals Cannabis-based Medicines Product Offered

11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 MGC Pharmaceuticals Main Business Overview

11.6.5 MGC Pharmaceuticals Latest Developments

11.7 ECHO Pharmaceuticals

11.7.1 ECHO Pharmaceuticals Company Information

11.7.2 ECHO Pharmaceuticals Cannabis-based Medicines Product Offered

11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 ECHO Pharmaceuticals Main Business Overview

11.7.5 ECHO Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cannabis-based Medicines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CBD (Cannabidiol) Based

Table 3. Major Players of THC (Tetrahydrocannabinol) Based

Table 4. Major Players of Others

Table 5. Cannabis-based Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

Table 8. Cannabis-based Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

Table 11. Global Cannabis-based Medicines Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Cannabis-based Medicines Revenue Market Share by Player (2020-2022)

Table 13. Cannabis-based Medicines Key Players Head office and Products Offered

Table 14. Cannabis-based Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Cannabis-based Medicines Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Cannabis-based Medicines Market Size Market Share by Regions (2017-2022)

Table 19. Americas Cannabis-based Medicines Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Cannabis-based Medicines Market Size Market Share by Country (2017-2022)

Table 21. Americas Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

Table 23. Americas Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

Table 25. APAC Cannabis-based Medicines Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Cannabis-based Medicines Market Size Market Share by Region (2017-2022)

Table 27. APAC Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

Table 29. APAC Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

Table 31. Europe Cannabis-based Medicines Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Cannabis-based Medicines Market Size Market Share by Country (2017-2022)

Table 33. Europe Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

Table 35. Europe Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Cannabis-based Medicines Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Cannabis-based Medicines

Table 44. Key Market Challenges & Risks of Cannabis-based Medicines

Table 45. Key Industry Trends of Cannabis-based Medicines

Table 46. Global Cannabis-based Medicines Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Cannabis-based Medicines Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Cannabis-based Medicines Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Cannabis-based Medicines Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Cannabis-based Medicines Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Cannabis-based Medicines Market Size Market Share Forecast by Application (2023-2028)

Table 52. GW Pharmaceuticals plc Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 53. GW Pharmaceuticals plc Cannabis-based Medicines Product Offered

Table 54. GW Pharmaceuticals plc Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. GW Pharmaceuticals plc Main Business

Table 56. GW Pharmaceuticals plc Latest Developments

Table 57. INSYS Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 58. INSYS Therapeutics Cannabis-based Medicines Product Offered

Table 59. INSYS Therapeutics Main Business

Table 60. INSYS Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. INSYS Therapeutics Latest Developments

Table 62. Aequus Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 63. Aequus Pharmaceuticals Cannabis-based Medicines Product Offered

Table 64. Aequus Pharmaceuticals Main Business

Table 65. Aequus Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Aequus Pharmaceuticals Latest Developments

Table 67. Axim Biotechnologies Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 68. Axim Biotechnologies Cannabis-based Medicines Product Offered

Table 69. Axim Biotechnologies Main Business

Table 70. Axim Biotechnologies Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Axim Biotechnologies Latest Developments

Table 72. Revive Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 73. Revive Therapeutics Cannabis-based Medicines Product Offered

Table 74. Revive Therapeutics Main Business

Table 75. Revive Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Revive Therapeutics Latest Developments

Table 77. MGC Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 78. MGC Pharmaceuticals Cannabis-based Medicines Product Offered

Table 79. MGC Pharmaceuticals Main Business

Table 80. MGC Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. MGC Pharmaceuticals Latest Developments

Table 82. ECHO Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors

Table 83. ECHO Pharmaceuticals Cannabis-based Medicines Product Offered

Table 84. ECHO Pharmaceuticals Main Business

Table 85. ECHO Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. ECHO Pharmaceuticals Latest Developments

List of Figures

Figure 1. Cannabis-based Medicines Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cannabis-based Medicines Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cannabis-based Medicines Market Size Market Share by Type in 2021

Figure 7. Cannabis-based Medicines in Oral Solution

Figure 8. Global Cannabis-based Medicines Market: Oral Solution (2017-2022) & ($ Millions)

Figure 9. Cannabis-based Medicines in Tablets

Figure 10. Global Cannabis-based Medicines Market: Tablets (2017-2022) & ($ Millions)

Figure 11. Cannabis-based Medicines in Patches

Figure 12. Global Cannabis-based Medicines Market: Patches (2017-2022) & ($ Millions)

Figure 13. Cannabis-based Medicines in Others

Figure 14. Global Cannabis-based Medicines Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Cannabis-based Medicines Market Size Market Share by Application in 2021

Figure 16. Global Cannabis-based Medicines Revenue Market Share by Player in 2021

Figure 17. Global Cannabis-based Medicines Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Cannabis-based Medicines Market Size 2017-2022 ($ Millions)

Figure 19. APAC Cannabis-based Medicines Market Size 2017-2022 ($ Millions)

Figure 20. Europe Cannabis-based Medicines Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Cannabis-based Medicines Market Size 2017-2022 ($ Millions)

Figure 22. Americas Cannabis-based Medicines Value Market Share by Country in 2021

Figure 23. Americas Cannabis-based Medicines Consumption Market Share by Type in 2021

Figure 24. Americas Cannabis-based Medicines Market Size Market Share by Application in 2021

Figure 25. United States Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Cannabis-based Medicines Market Size Market Share by Region in 2021

Figure 30. APAC Cannabis-based Medicines Market Size Market Share by Application in 2021

Figure 31. China Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Cannabis-based Medicines Market Size Market Share by Country in 2021

Figure 38. Europe Cannabis-based Medicines Market Size Market Share by Type in 2021

Figure 39. Europe Cannabis-based Medicines Market Size Market Share by Application in 2021

Figure 40. Germany Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Application in 2021

Figure 48. Egypt Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 54. APAC Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 55. Europe Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 57. United States Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 58. Canada Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 61. China Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 62. Japan Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 63. Korea Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 65. India Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 66. Australia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 67. Germany Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 68. France Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 69. UK Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 70. Italy Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 71. Russia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 72. Spain Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 75. Israel Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Cannabis-based Medicines Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450